Over the last four years, life for multiple-sclerosis patients has changed for the better as a new generation of powerful oral drugs has moved into a market dominated by injectables. But things aren’t done changing yet, as a September conference in Boston showed. At the meeting, held jointly by the American and European Committees for Treatment and Research in MS, the star presentation came from small biotech Receptos (RCPT). The phase-two
A company that makes radio frequency chips for smartphones and other products might not, at first blush, excite many investors. But if the company’s stock price doubles in a year, it might get an investor’s heart rate up. Investors have gotten on the same wavelength with the leading makers of RF chips, as all four of these companies have stocks that have far more than doubled over the past 12 months, performing among the top 2% of stocks in that
Accenture’s revenue ascended in its fiscal fourth quarter, but investors focused on the company’s Q4 earnings miss and lower-than-expected sales outlook for the current quarter. The global management consulting, technology and outsourcing service company announced its fourth-quarter numbers before the market opened Wednesday, results that showed its first double-digit revenue growth in more than two years. Accenture’s (ACN) Q4 revenue beat Wall